Literature DB >> 28285014

Vertebral fracture assessment: Enhancing the diagnosis, prevention, and treatment of osteoporosis.

Meltem Zeytinoglu1, Rajesh K Jain2, Tamara J Vokes2.   

Abstract

Osteoporosis is a highly prevalent condition, resulting in significant morbidity and mortality. Nevertheless, it is frequently untreated. Vertebral fractures often do not come to clinical attention, yet, their presence is diagnostic of osteoporosis, helps to predict the risk of future fractures, and may alter the choice of pharmacotherapy. The addition of lateral spine imaging technology to the densitometer, for vertebral fracture assessment (VFA), represented a major advancement in the ability to diagnose vertebral fractures and osteoporosis. VFA is an under-utilized and highly effective imaging tool to enhance osteoporosis detection and fracture prevention. Several factors make VFA an ideal technology to evaluate for vertebral fractures. These include: the ability to obtain the image at the same time the bone density is done, with significantly lower radiation exposure than with spine radiography, and at a lower cost. This review provides an overview of the clinical significance of identifying vertebral fractures, the origins of the VFA, its clinical indications, a review of the methods used to diagnose vertebral fracture, an overview on interpreting the VFA, and the strengths and limitations of this technique.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DXA; VFA; Vertebral fracture assessment; Vertebral fractures

Mesh:

Year:  2017        PMID: 28285014     DOI: 10.1016/j.bone.2017.03.004

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

1.  Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.

Authors:  E Kanterewicz; E Puigoriol; J R Rodríguez Cros; P Peris
Journal:  Osteoporos Int       Date:  2019-05-23       Impact factor: 4.507

2.  Association between handgrip strength and subsequent vertebral-fracture risk following percutaneous vertebral augmentation.

Authors:  Shu-Bao Zhang; Hao Chen; Hao-Wei Xu; Shan-Jin Wang; Yu-Yang Yi; De-Sheng Wu
Journal:  J Bone Miner Metab       Date:  2020-07-20       Impact factor: 2.626

3.  Diagnostic and Gradation Model of Osteoporosis Based on Improved Deep U-Net Network.

Authors:  Jian Liu; Jian Wang; Weiwei Ruan; Chengshan Lin; Daguo Chen
Journal:  J Med Syst       Date:  2019-12-07       Impact factor: 4.460

4.  Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism.

Authors:  S Saha; V Mannar; D Kandasamy; V Sreenivas; R Goswami
Journal:  J Endocrinol Invest       Date:  2022-05-19       Impact factor: 5.467

5.  A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.

Authors:  L-J Song; L-L Wang; L Ning; S-W Fan; X Zhao; Y-L Chen; Z-Z Li; Z-A Hu
Journal:  Osteoporos Int       Date:  2018-07-20       Impact factor: 4.507

Review 6.  Osteoporosis: what the clinician needs to know?

Authors:  Rosario Francesco Balzano; Maria Mattera; Xiaoguang Cheng; Samantha Cornacchia; Giuseppe Guglielmi
Journal:  Quant Imaging Med Surg       Date:  2018-02

Review 7.  Optimising the management of osteoporosis.

Authors:  Ziad Farrah; Ali Sm Jawad
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

8.  High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.

Authors:  P M Dussault; D McCarthy; S A Davis; M Thakore-James; A A Lazzari
Journal:  Osteoporos Int       Date:  2021-04-06       Impact factor: 4.507

9.  Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.

Authors:  Sofia Dalemo; Robert Eggertsen; Per Hjerpe; Erik G Almqvist; Kristina Bengtsson Boström
Journal:  Scand J Prim Health Care       Date:  2018-04-06       Impact factor: 2.581

10.  Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast - A Novel Concept for Osteoporosis Treatment: Part 1.

Authors:  Krzysztof Marycz; Agnieszka Smieszek; Klaudia Marcinkowska; Mateusz Sikora; Eliza Turlej; Paulina Sobierajska; Adrian Patej; Alina Bienko; Rafal J Wiglusz
Journal:  Int J Nanomedicine       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.